行情

ALPN

ALPN

Alpine Immune
NASDAQ

实时行情|Nasdaq Last Sale

2.970
+0.070
+2.41%
交易中 12:56 01/29 EST
开盘
2.900
昨收
2.900
最高
3.016
最低
2.909
成交量
4,397
成交额
--
52周最高
8.24
52周最低
2.250
市值
5,520.57万
市盈率(TTM)
-1.0761
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ALPN 新闻

  • 美联储维持利率在1.50%-1.75%不变 符合市场预期
  • 新浪财经.26分钟前
  • 市场摆脱对新冠病毒的担忧 欧股上涨
  • FX168.52分钟前
  • 欧洲议会表决通过“脱欧”协议 为英国脱欧铺平道路
  • 新浪财经.1小时前
  • 美国12月份二手房签约量录得2010年以来最大降幅
  • 新浪财经.2小时前

更多

所属板块

生物技术和医学研究
-0.06%
制药与医学研究
+0.38%

热门股票

名称
价格
涨跌幅

ALPN 简况

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
展开

Webull提供Alpine Immune Sciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。